Trial Profile
CSP 571 - Drug-eluting Stents vs. Bare Metal Stents in Saphenous Vein Graft Angioplasty (DIVA)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2022
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms DIVA
- 01 Nov 2021 Results published in the American Journal of Cardiology
- 25 Aug 2017 The study follow-up ended on December 31, 2016.
- 25 Aug 2017 Trial enrollment was terminated on December 31, 2015 due to slower enrollment than expected and funding considerations.